BIOCAPTIVA Secures US Patent for Advanced DNA-Extraction Technology in Cancer Management
BIOCAPTIVA, a biotech company based in Edinburgh, has been granted its first US patent for a liquid biopsy technology designed …
News
MGI Introduces New CycloneSEQ Nanopore Sequencing Products
MGI Tech Co., Ltd., a global developer of life science technologies, has launched two new nanopore sequencing products, CycloneSEQ-WT02 and …
Superluminal Medicines Raises $120 Million to Advance GPCR-Targeted Drug Discovery
Superluminal Medicines, Inc. has raised $120 million in a Series A funding round led by RA Capital Management, with participation …
Eli Lilly Partners with Genetic Leap in $409 Million AI-Driven Drug Discovery Deal
Eli Lilly has announced a partnership with Genetic Leap, a biotech company specializing in RNA-targeted drug discovery using AI models. …
ETH Zurich’s Flexible Brain Probes: A Safer Twist in the BCI Journey
Neuralink recently captured the public's attention with the implantation of its brain chip in a second patient, allowing the person …
Proscia Expands Concentriq Platform with Real-World Data to Enhance Precision Medicine
Proscia has announced a new real-world data offering on its Concentriq platform, integrating over 10 million de-identified pathology images with …
BioAge Labs Files for IPO with Focus on Anti-Aging Therapeutics and Metabolic Diseases
BioAge Labs, a clinical-stage biopharmaceutical company specializing in anti-aging and metabolic disease therapeutics, has filed for an initial public offering …
Noetik Secures $40 Million Series A to Accelerate AI-Driven Precision Cancer Therapies
Noetik, an emerging biotech firm specializing in the application of artificial intelligence (AI) to oncology, has announced the successful closure …
Brinter AM to Launch 3D Bioprinter to the International Space Station
Brinter AM Technologies Oy has been selected to provide a 3D bioprinter for a European Space Agency (ESA) project aimed …
Novartis' Phase III V-MONO Trial Demonstrates Efficacy of Leqvio in Reducing LDL-C in ASCVD Patients
Novartis has announced that its Phase III V-MONO clinical trial evaluating the small interfering RNA (siRNA) therapy Leqvio (inclisiran) in …
Flagship Pioneering and Quotient Therapeutics Partner with Pfizer to Advance Research in Cardiovascular and Renal Diseases
Flagship Pioneering and its subsidiary Quotient Therapeutics have announced a new research initiative under their strategic partnership with Pfizer to …
Bayer and NextRNA Therapeutics Partner to Develop Novel Small Molecule Drugs Targeting Long Non-Coding RNA in Cancer
Bayer and NextRNA Therapeutics have entered a strategic partnership to develop a new class of small molecule drugs targeting cancers …